Tipifarnib in Head and Neck Squamous Cell Carcinoma With<i>HRAS</i>Mutations - Concepedia

Concepedia

Publication | Open Access

Tipifarnib in Head and Neck Squamous Cell Carcinoma With<i>HRAS</i>Mutations

DOI Full Paper Access

186

Citations

28

References

2021

Year

Alan L. Ho, Irene Braña, Robert I. Haddad, Jessica R. Bauman, Keith C. Bible, Sjoukje F. Oosting, Deborah Jean Lee Wong, Myung‐Ju Ahn, Valentina Boni, Caroline Even,

Journal of Clinical Oncology

Abstract

Tipifarnib demonstrated encouraging efficacy in patients with R/M HNSCC with <i>HRAS</i> mutations for whom limited therapeutic options exist (NCT02383927).

References

	Year	Citations

Page 1